The effects of micronutrient-fortified complementary/replacement food on intestinal permeability and systemic markers of inflammation among maternally HIV-exposed and unexposed Zambian infants

Br J Nutr. 2012 Mar;107(6):893-902. doi: 10.1017/S0007114511003734. Epub 2011 Sep 8.

Abstract

The present randomised trial investigated the effects of feeding Zambian infants from 6 to 18 months old either a richly or basal micronutrient-fortified complementary/replacement food on gut integrity and systemic inflammation. Blood samples were obtained from all infants (n 743) at 6 and 18 months for the assessment of serum C-reactive protein (CRP) and α1-acid glycoprotein (AGP). A subsample of 502 infants, selected from the main cohort to include a larger proportion of infants with HIV-positive mothers, was assigned to lactulose/mannitol gut permeability tests. Lactulose:mannitol (L:M) ratio analyses were adjusted for baseline urinary L:M ratio, socio-economic status, mother's education, season of birth and baseline stunting, and stratified by maternal antenatal HIV status, child's sex, concurrent breast-feeding status and anaemia at baseline. There was no significant difference in geometric mean L:M ratio between the richly fortified and basal-fortified porridge arms at 12 months (0·47 (95 % CI 0·41, 0·55) v. 0·41 (95 % CI 0·34, 0·49); P = 0·16 adjusted). At 18 months, the richly fortified porridge group had a significantly higher geometric mean L:M ratio than the basal-fortified group (0·23 (95 % CI 0·19, 0·28) v. 0·15 (95 % CI 0·12, 0·19); P = 0·02 adjusted). This effect was evident for all stratifications, significantly among boys (P = 0·04), among the infants of HIV-negative mothers (P = 0·01), among the infants of HIV-negative mothers not concurrently breast-fed (P = 0·01) and among those who were not anaemic at baseline (P = 0·03). CRP, but not AGP, was positively associated with L:M ratio, but there were no significant effects of the diet on either CRP or AGP. In conclusion, a richly fortified complementary/replacement food did not benefit and may have worsened intestinal permeability.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anemia / complications
  • C-Reactive Protein / analysis*
  • Cohort Studies
  • Female
  • Food, Fortified* / analysis
  • HIV Seropositivity / congenital
  • HIV Seropositivity / immunology
  • HIV Seropositivity / physiopathology*
  • Humans
  • Infant
  • Infant Food* / analysis
  • Intestinal Absorption*
  • Intestines / immunology
  • Intestines / physiopathology
  • Lactulose / metabolism
  • Lactulose / urine
  • Lost to Follow-Up
  • Malabsorption Syndromes / complications
  • Malabsorption Syndromes / diet therapy*
  • Malabsorption Syndromes / etiology
  • Malabsorption Syndromes / physiopathology
  • Male
  • Mannitol / metabolism
  • Mannitol / urine
  • Micronutrients / therapeutic use*
  • Permeability
  • Sex Characteristics
  • Zambia

Substances

  • Micronutrients
  • Mannitol
  • Lactulose
  • C-Reactive Protein

Associated data

  • ISRCTN/ISRCTN37460449